ASX Share rice
Fri 07 Aug 2020 - 10:53:am (Sydney)

BIT Share Price

BIOTRON LIMITEDBITPharmaceuticals, Biotechnology & Life Sciences

BIT Company Information

Name:

Biotron Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

56 Delhi Road North Ryde NSW Australia 2113

Phone:

61 2 9805 0488

CEO, MD & Exec. Director:

Dr. Michelle Miller BSc., GCertAppFin, Ph.D., MSc.

Company Sec.:

Mr. Peter James Nightingale C.A., B.Econ, CA

Chief Medical Officer:

Dr. Stephen L. Becker M.D.

Company Overview:

Biotron Limited, a biotechnology company, develops and commercializes novel small molecule antiviral therapeutics to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also has a portfolio of preclinical antiviral programs developing drugs targeting a range of viral diseases, including Dengue, Zika, Influenza, Ebola, and SARs. Biotron Limited is based in North Ryde, Australia.

BIT Share Price Information

Shares Issued:

701.93M

Market Capitalisation:

$73.70M

Earnings per Share:

$-0.003

Return On Assets (TTM):

$-0.28

Return On Equity (TTM):

$-0.45

Quarterly Revenue Growth (YOY):

-1

Gross Profit(TTM):

$1.07M

Diluted Earnings Per Share (TTM):

$-0.006

BIT CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-52,882

Change To Liabilities:

$63.40K

Total Cashflow From Investing Activities:

$-52,882

Net Income:

$-1,611,799

Total Cash From Operating Activities:

$-1,497,891

Depreciation:

$12.47K

Other Cashflow From Investing Activities:

$-11,949

Sale Purchase Of Stock:

$-291,678

Capital Expenditures:

$40.93K

BIT Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-1,611,799

Net Income:

$-1,611,799

Gross Profit:

$1.07M

Operating Income:

$-2,773,771

Other Operating Expenses:

$404.49K

Total Revenue:

$1.07M

Total Operating Expenses:

$2.77M

BIT Balance Sheet

Balance Sheet Date:

2019-06-30

Total Liabilities:

$418K

Total Stockholder Equity:

$5.44M

Total Assets:

$5.86M

Common Stock:

$47.52M

Other Current Assets:

$37K

Retained Earnings:

$-42,369,108

Other Liabilities:

$5.91K

Other Assets:

$33.86K

Cash:

$5.74M

Total Current Liabilities:

$412.09K

Property - Plant & Equipment:

$46.32K

Net Tangible Assets:

$5.44M

Long-Term Investments:

$33.86K

Total Current Assets:

$5.78M

Short-Term Investments:

$80.18K

Accounts Payable:

$158.27K

Non Currrent Assets (Other):

$33.86K

Short-Term Investments:

$80.18

Non Current Liabilities Total:

$5.91K

BIT Share Price History

BIT News

22 May, 2020
We think that it's fair to say that the possibility of finding fantastic multi-year winners is what motivates many...
23 Mar, 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
23 Jan, 2020
Whilst it may not be a huge deal, we thought it was good to see that the Biotron Limited (ASX:BIT) Independent...
19 Dec, 2019
Michelle Miller is the CEO of Biotron Limited (ASX:BIT). First, this article will compare CEO compensation with...
20 Oct, 2019
As every investor would know, you don't hit a homerun every time you swing. But it should be a priority to avoid...
14 Sep, 2019
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...